TY  - GEN
AU  - Salama,J K
AU  - Haraf,D J
AU  - Stenson,K M
AU  - Blair,E A
AU  - Witt,M E
AU  - Williams,R
AU  - Kunnavakkam,R
AU  - Cohen,E E W
AU  - Seiwert,T
AU  - Vokes,E E
TI  - A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers
SN  - 1569-8041
PY  - 2011///1212
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bevacizumab
KW  - Carcinoma, Squamous Cell
KW  - drug therapy
KW  - Combined Modality Therapy
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Female
KW  - Fluorouracil
KW  - Head and Neck Neoplasms
KW  - Humans
KW  - Hydroxyurea
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Radiotherapy Dosage
KW  - Squamous Cell Carcinoma of Head and Neck
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/annonc/mdq736
ER  -